Common Contracts

EX-10.6 7 ex10-6.htm DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT Adamis Pharmaceuticals Corporation 10-Q Execution copy [*Designates portions of this document have been omitted pursuant to a request for confidential treatment filed separately...

Development, License and Commercialization Agreement • May 5th, 2020 • Delaware

• Contract Type
  Development, License and Commercialization Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

THIS DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is made and entered into on May 9, 2016 (the “Effective Date”), by and between Watson Laboratories, Inc., a Nevada corporation (“Watson”), on the one hand, and Adamis Pharmaceuticals Corporation, a company incorporated under the laws of Delaware (“Adamis”), on the other hand. Watson and Adamis shall each sometimes be referred to herein as a “Party” and collectively as the “Parties.”

Designates portions of this document have been omitted pursuant to a request for confidential treatment filed separately with the Commission] DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT

Development, License and Commercialization Agreement • August 15th, 2016 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Development, License and Commercialization Agreement
• Filed
  August 15th, 2016
• Company
  Adamis Pharmaceuticals Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is made and entered into on May 9, 2016 (the “Effective Date”), by and between Watson Laboratories, Inc., a Nevada corporation (“Watson”), on the one hand, and Adamis Pharmaceuticals Corporation, a company incorporated under the laws of Delaware (“Adamis”), on the other hand. Watson and Adamis shall each sometimes be referred to herein as a “Party” and collectively as the “Parties.”